Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neo Derm Group Sets Fooprint On Mainland China

This article was originally published in PharmAsia News

Executive Summary

Neo Derm Group, Hong Kong's largest cosmetic dermatology company, has invested RMB 20 million ($2.9 million) to set up its first mainland medical cosmetic center in Shanghai. The cosmetic center, unlike a beauty shop, is a professional dermatology clinic that has been granted a medical institution practice license by Shanghai Municipal Health Bureau. The beauty industry has become one of China's five-largest consumer sectors, with revenue hitting RMB 200 billion ($29.25 billion) in 2006 and expected to double in 2011. Neo Derm Group said that despite the challenging economic situation it has confidence in China's medical cosmetic market thanks to little competition there. The group plans to get listed on the Hong Kong Stock Exchange and set up three to five centers annually in the territory. It will also develop the China and Southeast Asia market. (Click here for more - Chinese Language)

Neo Derm Group, Hong Kong's largest cosmetic dermatology company, has invested RMB 20 million ($2.9 million) to set up its first mainland medical cosmetic center in Shanghai. The cosmetic center, unlike a beauty shop, is a professional dermatology clinic that has been granted a medical institution practice license by Shanghai Municipal Health Bureau. The beauty industry has become one of China's five-largest consumer sectors, with revenue hitting RMB 200 billion ($29.25 billion) in 2006 and expected to double in 2011. Neo Derm Group said that despite the challenging economic situation it has confidence in China's medical cosmetic market thanks to little competition there. The group plans to get listed on the Hong Kong Stock Exchange and set up three to five centers annually in the territory. It will also develop the China and Southeast Asia market. (Click here for more - Chinese Language)

"Neo Derm Group Enters Mainland China, Ready For Listing" - 21st Century Business Herald (Guangzhou) (1/13/09)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel